PT1404811E - O monóxido de carbono melhora os resultados nos transplantes de tecidos e de orgãos e suprime a apoptose - Google Patents

O monóxido de carbono melhora os resultados nos transplantes de tecidos e de orgãos e suprime a apoptose Download PDF

Info

Publication number
PT1404811E
PT1404811E PT02747932T PT02747932T PT1404811E PT 1404811 E PT1404811 E PT 1404811E PT 02747932 T PT02747932 T PT 02747932T PT 02747932 T PT02747932 T PT 02747932T PT 1404811 E PT1404811 E PT 1404811E
Authority
PT
Portugal
Prior art keywords
carbon monoxide
tissue
organ transplants
suppresses apoptosis
improves outcomes
Prior art date
Application number
PT02747932T
Other languages
English (en)
Inventor
Fritz H Bach
Jeanne GOSE
Edda M Tobiasch
Miguel C Soares
Leo E Otterbein
Original Assignee
Beth Israel Hospital
Univ Yale
Jeanne GOSE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27404726&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1404811(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beth Israel Hospital, Univ Yale, Jeanne GOSE filed Critical Beth Israel Hospital
Publication of PT1404811E publication Critical patent/PT1404811E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Physiology (AREA)
  • Environmental Sciences (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT02747932T 2001-06-21 2002-06-21 O monóxido de carbono melhora os resultados nos transplantes de tecidos e de orgãos e suprime a apoptose PT1404811E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30028901P 2001-06-21 2001-06-21
US33434001P 2001-11-29 2001-11-29
US33797401P 2001-12-07 2001-12-07

Publications (1)

Publication Number Publication Date
PT1404811E true PT1404811E (pt) 2009-01-22

Family

ID=27404726

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02747932T PT1404811E (pt) 2001-06-21 2002-06-21 O monóxido de carbono melhora os resultados nos transplantes de tecidos e de orgãos e suprime a apoptose

Country Status (26)

Country Link
US (2) US7238469B2 (pt)
EP (2) EP1404811B1 (pt)
JP (1) JP4521183B2 (pt)
KR (1) KR20040032115A (pt)
CN (1) CN100502650C (pt)
AT (1) ATE413883T1 (pt)
AU (2) AU2002318377B2 (pt)
BG (1) BG108492A (pt)
BR (1) BR0210599A (pt)
CA (1) CA2451266A1 (pt)
CY (1) CY1108798T1 (pt)
CZ (1) CZ20033448A3 (pt)
DE (1) DE60229848D1 (pt)
DK (1) DK1404811T3 (pt)
ES (1) ES2316583T3 (pt)
HK (1) HK1067380A1 (pt)
HU (1) HUP0400371A3 (pt)
MX (1) MXPA03012031A (pt)
NO (1) NO20035637L (pt)
NZ (1) NZ562962A (pt)
PL (1) PL367544A1 (pt)
PT (1) PT1404811E (pt)
SG (1) SG147305A1 (pt)
SI (1) SI1404811T1 (pt)
SK (1) SK15942003A3 (pt)
WO (1) WO2003000114A2 (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8128963B2 (en) * 1996-09-27 2012-03-06 The Trustees Of Columbia University In The City Of New York Methods for treating ischemic disorders using carbon monoxide
US7678390B2 (en) * 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
HUP0400371A3 (en) * 2001-06-21 2010-06-28 Beth Israel Hospital Use of carbon monoxide for preparation of pharmaceutical composition available for improving survival or function of organ following transplantation
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US7011854B2 (en) * 2002-02-04 2006-03-14 Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
WO2003072024A2 (en) 2002-02-13 2003-09-04 Beth Israel Deaconess Medical Center, Inc. Methods of treating vascular disease
AU2003216368B2 (en) 2002-04-15 2007-08-09 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods of treating ileus
RS91104A (en) * 2002-04-15 2007-02-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education, Methods of treating necrotizing enterocolitis
AU2003226366A1 (en) 2002-04-15 2003-11-03 Beth Israel Deaconess Medical Center Use of heme oxygenase-1 and products of heme degradation
CN1668314B (zh) 2002-05-17 2011-01-12 耶鲁大学 治疗肝炎的方法
PL374375A1 (en) * 2002-06-05 2005-10-17 Yale University Methods of treating angiogenesis, tumor growth, and metastasis
RS110504A (en) * 2002-06-21 2007-02-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education, Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
CN1719975A (zh) * 2002-11-07 2006-01-11 联邦高等教育系统匹兹堡大学 出血性休克的治疗
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
US20070207217A1 (en) * 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
WO2005041655A1 (en) * 2003-10-22 2005-05-12 Fred Hutchinson Cancer Research Center Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
EP1552840A1 (en) * 2004-01-07 2005-07-13 Aga Ab Use of a xenon/carbon monoxide mixture for the protection of cells
US20060234915A1 (en) * 2005-03-07 2006-10-19 Sangart, Inc. Compositions and methods for delivering carbon monoxide (CO) and nitric oxide (NO) to tissue using heme proteins as carriers
EP1937059A2 (en) 2005-07-27 2008-07-02 University Of North Carolina At Charlotte Composition and method for the restoration and preservation of transplant organs procured from dcd donors
US20070207993A1 (en) * 2005-12-20 2007-09-06 Alfama - Investigacao E Desenvolvimetno De Productos Farmaceuticos Lda Molybdenum carbonyl complexes for treating rheumatoid arthritis and other inflammatory diseases
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
US8887721B2 (en) 2006-11-07 2014-11-18 The General Hospital Corporation Attenuation of vasoactive oxygen carrier-induced vasoconstriction
SG176149A1 (en) 2009-05-27 2011-12-29 Ikaria Holdings Inc Devices and methods for engaging indexed valve and pressurized canister assembly with collar and for linear actuation by plunger assembly into fluid communication with device for regulating drug delivery
JP2011010865A (ja) 2009-06-30 2011-01-20 Ikaria Holdings Inc 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法
EP2663193B1 (en) 2011-01-14 2019-05-08 Children's Hospital Los Angeles Solution of carbon monoxide for treatment of disease, including sickle cell disease
US8927750B2 (en) 2011-02-04 2015-01-06 Universitaet Zu Koeln Acyloxy- and phosphoryloxy-butadiene-Fe(CO)3 complexes as enzyme-triggered co-releasing molecules
JP2014510731A (ja) 2011-03-16 2014-05-01 メイヨー ファンデーション フォー メディカル エデュケーション アンド リサーチ 赤血球製剤および血小板製剤の有効貯蔵を延ばすための方法および材料
ES2656237T3 (es) 2011-04-19 2018-02-26 Alfama, Inc. Moléculas liberadoras de monóxido de carbono y usos de las mismas
EP3391891A3 (en) * 2011-06-10 2019-01-02 VERO Biotech LLC Pressurized vessel of nitric oxide (no)
EP2734235B1 (en) 2011-07-21 2017-03-22 Alfama, Inc. Ruthenium carbon monoxide releasing molecules and uses thereof
WO2013022946A1 (en) 2011-08-09 2013-02-14 Beth Israel Deaconess Medical Center, Inc. Methods of treating dna damage
ES2981406T3 (es) 2013-03-15 2024-10-08 Mallinckrodt Pharmaceuticals Ireland Ltd Administración y monitorización de óxido nítrico en fluidos ex vivo
US9629358B2 (en) 2013-03-15 2017-04-25 Mallinckrodt Hospital Products IP Limited Administration and monitoring of nitric oxide in ex vivo fluids
TW201618795A (zh) 2014-04-15 2016-06-01 波泰里斯股份有限公司 用以改良器官功能及延長器官移植物壽命之系統及方法
CN105288599A (zh) * 2015-10-22 2016-02-03 徐州医学院 血红素氧化酶-2在制备抑制器官移植免疫排斥制剂中的应用
JP7249331B2 (ja) * 2017-08-25 2023-03-30 マリンクロット ホスピタル プロダクツ アイピー アンリミテッド カンパニー 器官の生存率を改善する方法
EP3524290A1 (en) 2018-02-09 2019-08-14 Julius-Maximilians-Universitaet Wuerzburg Method and system for monitoring carbon monoxide (co) administration to ex-vivo fluids
CN116076484A (zh) * 2022-11-30 2023-05-09 武汉大学 一种修复肾脏损伤的低温携氧机械灌注液及其应用

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053590A (en) * 1975-02-27 1977-10-11 Alza Corporation Compositions of matter comprising macromolecular hemoglobin
US4264739A (en) * 1979-01-05 1981-04-28 Merck & Co., Inc. Sparger for cell culture system
JPS5679957A (en) 1979-12-05 1981-06-30 Sogo Seibutsu Igaku Kenkyusho:Kk Erucinia enterocolitica polysaccharide sensitizing blood cell and method of detecting erucinia enterocolitica polysaccharide antibody using this
US5240912A (en) * 1983-05-09 1993-08-31 Todaro George J Transforming growth factor (TGF) peptides
US5084380A (en) * 1985-01-29 1992-01-28 Applied Biotechnology Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
CN85202057U (zh) * 1985-05-31 1986-09-10 南京低压阀门厂 电热丝预热凹槽式燃油系统
US5449665A (en) * 1985-09-24 1995-09-12 Item Development Aktiebolag Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty
DE3739650C1 (de) * 1987-11-23 1989-05-24 Immuno Ag Fermenter zum Zuechten von Zellkulturen
DE3928144A1 (de) * 1989-08-25 1991-02-28 Hoechst Ag Zyklische pyridin-2,4- und -2,5-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
US5180366A (en) * 1990-10-10 1993-01-19 Woods W T Apparatus and method for angioplasty and for preventing re-stenosis
US5792325A (en) * 1990-11-15 1998-08-11 Richardson, Jr.; William H. Electric arc material processing system
US5570683A (en) 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
US5396882A (en) 1992-03-11 1995-03-14 The General Hospital Corporation Generation of nitric oxide from air for medical uses
US5293875A (en) * 1992-06-16 1994-03-15 Natus Medical Incorporated In-vivo measurement of end-tidal carbon monoxide concentration apparatus and methods
ES2219646T5 (es) * 1993-02-22 2008-11-01 Abraxis Bioscience, Inc. Metodos para la administracion in vivo de compuestos biologicos y composiciones utiles para los mismos.
AU6523194A (en) 1993-03-26 1994-10-24 Biorelease Technologies, Inc. Compositions including heme-containing proteins and methods relating thereto
US5763431A (en) * 1993-08-20 1998-06-09 Jackson; Meyer B. Method for regulating neuropeptide hormone secretion
DE4421433C1 (de) * 1994-06-18 1995-06-08 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Wirkstoffen, die Kohlenmonoxid-Quellen darstellen, Verfahren zu seiner Herstellung und seine Verwendung
US5476764A (en) * 1994-09-16 1995-12-19 The Regents Of The University Of California Method using CO for extending the useful shelf-life of refrigerated red blood cells
US6066333A (en) * 1994-09-22 2000-05-23 William Harvey Research Limited Pharmaceutical control of inflammation
US5664563A (en) * 1994-12-09 1997-09-09 Cardiopulmonary Corporation Pneumatic system
US5914316A (en) * 1994-12-16 1999-06-22 Washington University Method of inhibiting intimal hyperplasia
US6063407A (en) 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US5712293A (en) * 1995-06-07 1998-01-27 Sepracor, Inc. Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride
FR2735382B1 (fr) * 1995-06-15 1997-07-25 Air Liquide Installation de production de monoxyde de carbone incorporant une unite de separation cryogenique
WO1997002036A1 (en) * 1995-06-30 1997-01-23 Zymogenetics, Inc. 4-(2-(n-2-carboxamidoindole)aminoethyl)-benzenesulfonamides or sulfonylureas as pdgf antagonists
WO1997037644A1 (en) * 1996-04-05 1997-10-16 The General Hospital Corporation Treatment of a hemoglobinopathy
US6069132A (en) * 1996-08-14 2000-05-30 Revanker; Ganapathi R. Phosphazole compounds
ES2210585T3 (es) 1996-08-27 2004-07-01 Messer Griesheim Gmbh Medicamento que contiene hidrogeno.
US8128963B2 (en) * 1996-09-27 2012-03-06 The Trustees Of Columbia University In The City Of New York Methods for treating ischemic disorders using carbon monoxide
WO1998013058A1 (en) * 1996-09-27 1998-04-02 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US6315995B1 (en) 1996-09-27 2001-11-13 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US6316403B1 (en) * 1996-09-27 2001-11-13 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US5869538A (en) * 1996-11-26 1999-02-09 Research Foundation Of State University Of New York Method for enhancing transport of gases to tissues
FR2757259B1 (fr) * 1996-12-18 1999-03-05 Valeo Thermique Moteur Sa Ailette metallique perfectionnee pour echangeur de chaleur, notamment pour vehicule automobile
US5912019A (en) * 1997-02-07 1999-06-15 Musc Foundation For Research Development Compounds for reducing ischemia/reperfusion injury
WO1999047512A1 (en) 1998-03-16 1999-09-23 Colgene Corporation 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
US6203991B1 (en) * 1998-08-21 2001-03-20 The Regents Of The University Of Michigan Inhibition of smooth muscle cell migration by heme oxygenase I
US7678390B2 (en) * 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
US20050250688A1 (en) * 1999-04-01 2005-11-10 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US6558825B1 (en) * 2000-05-12 2003-05-06 Reveo, Inc. Fuel containment and recycling system
FR2812197B1 (fr) 2000-07-27 2003-01-03 Air Liquide Sante Int Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
FR2816212A1 (fr) 2000-11-03 2002-05-10 Air Liquide Sante Int Utilisation de monoxyde de carbone (co) dans le traitement des inflammations du systeme cardiovasculaire
WO2002080859A2 (en) * 2001-03-20 2002-10-17 Glaxo Group Limited Inhalation drug combinations
US20030068387A1 (en) * 2001-03-30 2003-04-10 Roland Buelow Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
EP1395241B9 (en) * 2001-05-25 2005-06-15 Medtronic, Inc. Implantable medical device with controllable gaseous agent release system
HUP0400371A3 (en) * 2001-06-21 2010-06-28 Beth Israel Hospital Use of carbon monoxide for preparation of pharmaceutical composition available for improving survival or function of organ following transplantation
US7011854B2 (en) * 2002-02-04 2006-03-14 Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
WO2003072024A2 (en) * 2002-02-13 2003-09-04 Beth Israel Deaconess Medical Center, Inc. Methods of treating vascular disease
RS91104A (en) * 2002-04-15 2007-02-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education, Methods of treating necrotizing enterocolitis
AU2003216368B2 (en) * 2002-04-15 2007-08-09 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods of treating ileus
AU2003226366A1 (en) * 2002-04-15 2003-11-03 Beth Israel Deaconess Medical Center Use of heme oxygenase-1 and products of heme degradation
CN1668314B (zh) * 2002-05-17 2011-01-12 耶鲁大学 治疗肝炎的方法
PL374375A1 (en) * 2002-06-05 2005-10-17 Yale University Methods of treating angiogenesis, tumor growth, and metastasis
RS110504A (en) * 2002-06-21 2007-02-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education, Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
CN1719975A (zh) * 2002-11-07 2006-01-11 联邦高等教育系统匹兹堡大学 出血性休克的治疗
US20050255178A1 (en) * 2004-02-04 2005-11-17 Bloch Kenneth D Enhancing the effectiveness of an inhaled therapeutic gas

Also Published As

Publication number Publication date
WO2003000114A9 (en) 2004-05-21
CA2451266A1 (en) 2003-01-03
CY1108798T1 (el) 2014-04-09
HUP0400371A3 (en) 2010-06-28
NO20035637L (no) 2004-02-17
ATE413883T1 (de) 2008-11-15
SI1404811T1 (sl) 2009-04-30
MXPA03012031A (es) 2005-07-01
SG147305A1 (en) 2008-11-28
WO2003000114A2 (en) 2003-01-03
EP1404811A4 (en) 2006-08-09
DE60229848D1 (de) 2008-12-24
WO2003000114A3 (en) 2003-04-10
ES2316583T3 (es) 2009-04-16
PL367544A1 (en) 2005-02-21
HK1067380A1 (en) 2005-04-08
SK15942003A3 (sk) 2004-08-03
BG108492A (en) 2005-02-28
BR0210599A (pt) 2004-07-20
EP2033514A2 (en) 2009-03-11
KR20040032115A (ko) 2004-04-14
EP2033514A3 (en) 2009-04-29
CN1545548A (zh) 2004-11-10
US20070202083A1 (en) 2007-08-30
JP2005500875A (ja) 2005-01-13
AU2002318377B2 (en) 2008-06-19
JP4521183B2 (ja) 2010-08-11
DK1404811T3 (da) 2009-03-02
HUP0400371A2 (hu) 2004-08-30
CZ20033448A3 (cs) 2004-05-12
US7238469B2 (en) 2007-07-03
EP1404811B1 (en) 2008-11-12
NZ562962A (en) 2009-08-28
US20030039638A1 (en) 2003-02-27
NO20035637D0 (no) 2003-12-17
CN100502650C (zh) 2009-06-24
EP1404811A2 (en) 2004-04-07
AU2008221551A1 (en) 2008-10-09

Similar Documents

Publication Publication Date Title
HK1067380A1 (en) Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
WO2004009767A3 (en) Cell therapy for regeneration
WO2003077865A3 (en) Methods and compositions for directing cells to target organs
MXPA02007137A (es) Fuente de tejido hepatico.
DK1028737T3 (da) Humane mesenchymale stamceller fra perifert blod
DK1019493T3 (da) Fremstilling af hæmatopoietiske celler fra multipotente neurale stamceller
WO2004113513A3 (en) Methods and compositions for modulating stem cell growth and differentiation
EP1100870A4 (en) ENHANCING CARDIAC FUNCTIONING BY TRANSPLANTATION OF MESENCHYMAL STEM CELLS
EP1937802A4 (en) USE OF SMALL INTERFERING RNA IN ORGAN CONSERVATION / REPERFUSION SOLUTIONS
AU2002331356A1 (en) Nanoparticles for dna administration to a target organ
DK1274464T3 (da) Sammensætninger og fremgangsmåder til regulering af proteinekspression i tarm
EP2216033A3 (en) Methods of treating disease by transplantation of allogeneic or xenogeneic organs or tissues
WO2005047469A3 (en) PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
WO2007139939A3 (en) Methods and compositions using immunomodulatory compounds in combination therapy
IL190289A0 (en) Method for obtaining human smooth muscular cells and uses thereof
WO2002098361A3 (en) T cell induced tissue repair and regeneration
CA3198027A1 (en) Cells, tissues, organs, and animals having one or more modified genes for enhanced xenograft survival and tolerance
IL126014A0 (en) Method of killing target cells in harvested cell populations with one or more immunotoxins
WO2003078607A3 (en) Tissue specific signal-plexes to dedifferentiate and redifferentiate cells
WO2003029432A3 (en) Human mesenchymal progenitor cell
SG155212A1 (en) Methods for identifying factors for differentiating definitive endoderm
DK0652943T3 (da) Hæmatopoietiske, fremmende celler og anvendelse deraf
GB2379446A (en) Cells,culture methods and their uses
AU8478601A (en) Methods for culturing human lung mast cells and uses thereof
HUP0103107A2 (hu) Allogénikus és xenogénikus T-sejtek ex vivo kezelése gp39 antagonistákkal